GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) » Definitions » EPS (Diluted)

Zylox-Tonbridge Medical Technology Co (HKSE:02190) EPS (Diluted) : HK$-0.26 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Zylox-Tonbridge Medical Technology Co EPS (Diluted)?

Zylox-Tonbridge Medical Technology Co's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$-0.14. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.26.

Zylox-Tonbridge Medical Technology Co's EPS (Basic) for the six months ended in Dec. 2023 was HK$-0.14. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.26.

Zylox-Tonbridge Medical Technology Co's EPS without NRI for the six months ended in Dec. 2023 was HK$-0.10. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.23.

During the past 3 years, the average EPS without NRIGrowth Rate was 14.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Zylox-Tonbridge Medical Technology Co's highest 3-Year average EPS without NRI Growth Rate was 14.70% per year. The lowest was -15.10% per year. And the median was -0.20% per year.


Zylox-Tonbridge Medical Technology Co EPS (Diluted) Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zylox-Tonbridge Medical Technology Co EPS (Diluted) Chart

Zylox-Tonbridge Medical Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
-0.23 -0.37 -0.83 -0.38 -0.26

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only -0.48 -0.09 -0.29 -0.12 -0.14

Competitive Comparison of Zylox-Tonbridge Medical Technology Co's EPS (Diluted)

For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zylox-Tonbridge Medical Technology Co's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's PE Ratio falls into.



Zylox-Tonbridge Medical Technology Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Zylox-Tonbridge Medical Technology Co's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-86.118-0)/328.711
=-0.26

Zylox-Tonbridge Medical Technology Co's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-47.273-0)/327.739
=-0.14

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zylox-Tonbridge Medical Technology Co  (HKSE:02190) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Zylox-Tonbridge Medical Technology Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Zylox-Tonbridge Medical Technology Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Zylox-Tonbridge Medical Technology Co (HKSE:02190) Business Description

Traded in Other Exchanges
N/A
Address
No. 18 Keji Avenue, Yuhang Street, 1st & 2nd Floors, Building 1, Yuhang District, Zhejiang Province, Hangzhou, CHN
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries.
Executives
Gan Zhou Ti Tan Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo 2501 Other
Su Zhou Tai Hong Jing Hui Tou Zi Zhong Xin You Xian He Huo 2501 Other
Five Investment Limited 2501 Other
Highlight Medical Limited 2501 Other
Ourea Biotech Hk Limited 2501 Other
Wang Stephen Hui 2201 Interest of corporation controlled by you
Ning Bo Bao Shui Qu Tie Si Yi Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo 2501 Other
Jia Jian Tou Zi You Xian Gong Si 2501 Other
Wea Enterprises ,llc 2401 A concert party to an agreement to buy shares
Hu Zhou Yu Yi Hui Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2401 A concert party to an agreement to buy shares
Ning Bo Gui Qiao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2401 A concert party to an agreement to buy shares
Zhu Hai Gui Chuang Gu Quan Tou Zi Zhong Xin You Xian He Huo 2401 A concert party to an agreement to buy shares
Hang Zhou Fu Jiang Tou Zi He Huo Qi Ye You Xian He Huo 2401 A concert party to an agreement to buy shares
Zhu Hai Tong Qiao Tou Zi Zhong Xin You Xian He Huo 2401 A concert party to an agreement to buy shares
Li Zheng 2501 Other

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Headlines

No Headlines